Cydectin TriclaMox 5 mg/ml + 200 mg/ml Pour-on Solution for Cattle

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: VMD (Veterinary Medicines Directorate)

Ingredjent attiv:

Moxidectin, Triclabendazole

Disponibbli minn:

Zoetis UK Limited

Kodiċi ATC:

QP54AB52

INN (Isem Internazzjonali):

Moxidectin, Triclabendazole

Għamla farmaċewtika:

Pour-on solution

Tip ta 'preskrizzjoni:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Grupp terapewtiku:

Cattle

Żona terapewtika:

Endectocide

L-istatus ta 'awtorizzazzjoni:

Authorized

Data ta 'l-awtorizzazzjoni:

2012-03-05

Karatteristiċi tal-prodott

Revised: December 2020
AN: 00880/2020
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cydectin TriclaMox 5 mg/ml + 200 mg/ml Pour-on Solution for cattle
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCES:
Moxidectin
5.0 mg
Triclabendazole
200.0 mg
EXCIPIENTS:
Butylhydroxytoluene (E321)
5.0 mg
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Pour-on solution.
A clear, amber liquid.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cattle:
Treatment of mixed trematode (fluke) and nematode infections and
certain
arthropod infestations caused by moxidectin and triclabendazole
sensitive strains
of:
Revised: December 2020
AN: 00880/2020
Page 2 of 8
Parasite
Adult stage
Inhibited stages
NEMATODES
L4 GASTRO-INTESTINAL NEMATODES:
_Haemonchus placei_
●
●
_Ostertagia ostertagi_
●
●
●
_Trichostrongylus axei_
●
●
_Nematodirus helvetianus_
●
●
_Cooperia oncophora_
●
●
_Cooperia punctata_
●
_Oesophagostomum radiatum_
●
_Bunostomum phlebotomum_
●
RESPIRATORY TRACT NEMATODE:
_Dictyocaulus viviparus_
●
TREMATODES
LIVER FLUKE:
6 – 8 weeks
immatures
_Fasciola hepatica_
●
●
ECTOPARASITES
_Linognathus vituli_
●
_Bovicola bovis_
●
_Solenopotes capillatus_
●
The product has a persistent effect in preventing re-infection by
_Ostertagia ostertagi_
and by _Dictyocaulus viviparus_ for 5 weeks after a single dose.
4.3
CONTRAINDICATIONS
Do not use in cases of known hypersensitivity to the active
substance(s) or to any of
the excipient(s).
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately result in
ineffective therapy:
Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
Underdosing, which may be due to underestimation of body weight,
misadministration of the product, or lack o